This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty pharmaceutical product. The contract has a ceiling value of $2,217.44 and a completion date of December 5, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. The contract will contribute to the DLA's responsibility of supplying essential medical commodities, including specialty medications, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/5/25, 10:01 AM